The year in charts

To advance research on membrane proteins leadXpro collaborates with Orbion. Orbion has a new Astra AI model that can further enhance our membrane protein platform. This partnership highlights Orbion’s dedication to delivering practical, valuable guidance for protein research and leadXpro’s commitment to integrating machine learning into its technology platform. The collaboration will strengthe

ORYL Photonics announces the successful closing of its Series A round. The round was backed by existing shareholders. Their investment commitment has been achieved in record time of two weeks. This milestone marks a major step forward for the fast-growing Swiss company, which is pioneering advanced solutions for measuring the solubility and aggregation of drug molecules and biologics in the life s

Topadur Pharma AG today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its investigational therapy TOP-N53 for the treatment of digital ulcers in patients with systemic sclerosis.

In a groundbreaking collaboration, abc biopply AG, the Zurich University of Applied Sciences (ZHAW), and the University of Zurich (UZH) have joined forces to develop a next-generation 3D multi-organoid in vitro platform designed to transform drug development and personalized cancer therapy. The initiative is supported by the Swiss national funding agency Innosuisse.

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, has announced a significant new collaboration with Jessa Ziekenhuis in Hasselt, Belgium. The institutions will partner to bring cutting edge genomic testing and oncology research to cancer patients across Belgium.